Format

Send to

Choose Destination
J Thromb Thrombolysis. 2011 Apr;31(3):353-66. doi: 10.1007/s11239-011-0569-6.

Heparin-induced thrombocytopenia: present and future.

Author information

1
Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. adam.cuker@uphs.upenn.edu

Abstract

Heparin-induced thrombocytopenia (HIT) is a prothrombotic and potentially devastating complication of heparin therapy due to formation of platelet-activating antibodies against complexes of platelet factor 4 and heparin. Over the last several decades, great advances in our understanding of HIT have elevated a once enigmatic syndrome, the mere existence of which was doubted by the medical community, to a well-characterized disorder. Nevertheless, critical questions remain unanswered. The objective of this review is to examine our current understanding of the epidemiology, pathophysiology, diagnosis, and management of HIT and to highlight areas of future inquiry.

PMID:
21327506
DOI:
10.1007/s11239-011-0569-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center